These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 9740539)

  • 21. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
    Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
    Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine.
    Aggarwal A; Kruczynski A; Frankfurter A; Correia JJ; Lobert S
    Invest New Drugs; 2008 Aug; 26(4):319-30. PubMed ID: 18071633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
    Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
    Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo reversal of cancer cell multidrug resistance by the semi-synthetic antibiotic tiamulin.
    Baggetto LG; Dong M; Bernaud J; Espinosa L; Rigal D; Bonvallet R; Marthinet E
    Biochem Pharmacol; 1998 Nov; 56(9):1219-28. PubMed ID: 9802334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor.
    Didier A; Loor F
    Anticancer Drugs; 1996 Sep; 7(7):745-51. PubMed ID: 8949985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
    Koizumi S; Konishi M; Ichihara T; Wada H; Matsukawa H; Goi K; Mizutani S
    Eur J Cancer; 1995 Sep; 31A(10):1682-8. PubMed ID: 7488425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous overexpression of the long form of the Bcl-X protein in a highly resistant P388 leukaemia.
    Kühl JS; Krajewski S; Durán GE; Reed JC; Sikic BI
    Br J Cancer; 1997; 75(2):268-74. PubMed ID: 9010037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication.
    Munagala S; Sirasani G; Kokkonda P; Phadke M; Krynetskaia N; Lu P; Sharom FJ; Chaudhury S; Abdulhameed MD; Tawa G; Wallqvist A; Martinez R; Childers W; Abou-Gharbia M; Krynetskiy E; Andrade RB
    Bioorg Med Chem; 2014 Feb; 22(3):1148-55. PubMed ID: 24405813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
    Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
    Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of doxorubicin resistance in P388/ADR cells by Ro44-5912, a tiapamil derivative.
    De Jong G; Gelmon K; Bally M; Goldie J; Mayer L
    Anticancer Res; 1995; 15(3):911-6. PubMed ID: 7645981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.
    Stein U; Walther W; Lemm M; Naundorf H; Fichtner I
    Int J Cancer; 1997 Sep; 72(5):885-91. PubMed ID: 9311609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
    Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells.
    Bähr O; Rieger J; Duffner F; Meyermann R; Weller M; Wick W
    Brain Pathol; 2003 Oct; 13(4):482-94. PubMed ID: 14655754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulsed exposure of SDZ PSC 833 to multidrug resistant P388/ADR and MCF7/ADR cells in the absence of anticancer drugs can fully restore sensitivity to doxorubicin.
    Krishna R; de Jong G; Mayer LD
    Anticancer Res; 1997; 17(5A):3329-34. PubMed ID: 9413167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells.
    Kim HM; Oh GT; Hong DH; Kim MS; Kang JS; Park SM; Han SB
    FEBS Lett; 1997 Jul; 412(1):201-6. PubMed ID: 9257720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
    Nielsen D; Maare C; Eriksen J; Litman T; Skovsgaard T
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1050-7. PubMed ID: 11704330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.
    Tiberghien F; Loor F
    Anticancer Drugs; 1996 Jul; 7(5):568-78. PubMed ID: 8862725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characterization of the mechanism of cross-resistance to vinca alkaloids and taxoids in the human J82 bladder tumor cell line].
    Debal V; Allam N; Morjani H; Millot JM; Gourdier B; Breillout F; Manfait M
    Bull Cancer; 1994 Oct; 81(10):891-3. PubMed ID: 7734773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.